ARCHIVES

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs

November 29, 1991

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

February 25, 1994

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Price Increase

July 22, 1983